Skip to content

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

mars 27, 2017

170323  FDA / US Food & Drug Administration

If you have breast implants, there is no need to change your routine medical care and follow-up. BIA-ALCL is rare. Although not specific to BIA-ALCL, you should follow standard medical recommendations including:

  • Follow your doctor’s instructions on how to monitor your breast implants. If you notice any changes, contact your health care provider promptly to schedule an appointment. Get routine mammography screening and ask for a technologist specifically trained in performing mammograms on patients with breast implants.
  • If you have silicone gel-filled breast implants, get periodic magnetic resonance imaging (MRI) to detect ruptures as recommended by your health care provider. The FDA-approved product labeling for silicone gel-filled breast implants states that the first MRI should occur three years after implant surgery and every two years thereafter.

To improve our understanding of this rare finding, please continue to report all confirmed cases of ALCL in women with breast implants, with as much detail as possible, through FDA’s MedWatch Program.

We will continue to report on significant findings as new information and analyses become available.


Läs hela artikeln